Ameriprise Financial Inc Abbott Laboratories Transaction History
Ameriprise Financial Inc
- $381 Billion
- Q3 2024
A detailed history of Ameriprise Financial Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Ameriprise Financial Inc holds 12,084,392 shares of ABT stock, worth $1.34 Billion. This represents 0.36% of its overall portfolio holdings.
Number of Shares
12,084,392
Previous 10,675,827
13.19%
Holding current value
$1.34 Billion
Previous $1.11 Billion
24.2%
% of portfolio
0.36%
Previous 0.3%
Shares
29 transactions
Others Institutions Holding ABT
# of Institutions
3,198Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$18.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.52 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.3 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$5.92 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $195B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...